Interferon-free treatment using daclatasvir (Daklinza) and sofosbuvir (Sovaldi),
with or without ribavirin, was well-tolerated and produced sustained
virological response rates of 95-100% for people with HIV and HCV co-infection and
advanced liver disease, ...